Open an account

Neogen

NEOG · NASDAQ

$11.72+$0.09 (+0.77%)TodayMarket closed ·
Prev close $11.63

About NEOG

Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. The company is headquartered in Lansing, Michigan and currently employs 2,974 full-time employees. The firm has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.

Employees
2,974
Headquarters
Lansing, Michigan
Listed
Aug 23, 1989
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
neogen.com

NEOG key statistics

Market cap
2.56B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
5.13M
Volume
2.32M
Open price
$11.66
High today
$11.84
Low today
$11.59
52 Week high
$14.26
52 Week low
$5.37

Neogen (NEOG) at a glance

Neogen (NEOG) last traded at $11.72, with a market cap of 2.56B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $11.59 and $11.84. The current price is 1.1% above the day's low and 1.0% below its high.

Volume so far is 2.32M shares, below the average of 5.13M shares a day.

Over the past year Neogen has ranged from $5.37 to $14.26, and now sits 71% of the way up that range.

Neogen met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q3 FY26 it reported -$0.05 per share against an estimate of -$0.0714.

The average analyst price target is $13.32, 13.6% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 6 analystsAvg $13.32
Low
$10.32
Now
$11.72
High
$14.70

NEOG earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 40.5% on average.

  1. Q4 FY24: reported $0.10 per share against an estimate of $0.1173
  2. Q1 FY25: reported $0.07 per share against an estimate of $0.0867
  3. Q2 FY25: reported $0.11 per share against an estimate of $0.0986
  4. Q3 FY25: reported $0.10 per share against an estimate of $0.1122
  5. Q4 FY25: reported $0.05 per share against an estimate of $0.0765
  6. Q1 FY26: reported $0.04 per share against an estimate of $0.0204
  7. Q2 FY26: reported -$0.05 per share against an estimate of -$0.0663
  8. Q3 FY26: reported -$0.05 per share against an estimate of -$0.0714

NEOG news

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG

  • Press releaseGlobe Newswire

    Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Akanksha Bakshi

    Why Is Neogen Stock Gaining Thursday?

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG

  • Press releaseBusiness Wire

    Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day

  • Vandana Singh

    Neogen Shifts Focus to Scale Profitable Growth

Similar companies

Companies in the same industry as Neogen

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.